Recombinant Human IAPP Protein，His

The research on IAPP (islet amyloid polypeptide) recombinant proteins has gained significant attention due to their implications in diabetes mellitus, particularly Type 2 diabetes. IAPP, co-secreted with insulin by pancreatic beta cells, plays a crucial role in glucose metabolism and appetite regulation. However, under pathological conditions, IAPP can misfold and aggregate to form amyloid fibrils, which are toxic to beta cells and contribute to beta-cell dysfunction and death. The increasing prevalence of Type 2 diabetes worldwide has prompted investigations into the mechanisms underlying IAPP aggregation and its role in disease progression. By studying recombinant forms of IAPP, researchers aim to elucidate the molecular pathways involved in amyloid formation and investigate potential therapeutic approaches to prevent or reverse beta-cell damage. Understanding the folding properties and aggregation behavior of these recombinant proteins can lead to the development of novel strategies that may include amyloid inhibitors, anti-aggregating agents, and regenerative therapies for diabetic patients. This research is not only vital for advancing our knowledge of diabetes pathology but also holds promise for innovative treatment options that could improve the quality of life for millions affected by this chronic condition.